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Background/aim: To investigate the relationship between subfertility etiologies and success rates in controlled ovarian stimulation and
intrauterine insemination (COS–IUI) cycles.
Materials and methods: The medical records of 218 couples who applied to a university-based fertility center were analyzed
retrospectively. Detailed infertility examination data and pregnancy outcomes were compared according to different subfertility
etiologies. The study groups with regard to subfertility etiologies were minimal–mild endometriosis, unexplained infertility, and mild
male infertility. The primary outcome measure was live birth rate.
Results: There were no statistically significant differences between the groups regarding demographics except for total motile sperm
count. Live birth rates in the male infertility group were comparable to the endometriosis and unexpected infertility groups (6.6%,
11.9%, and 10.3%, respectively; P = 0.63).
Conclusion: The success rate of the mild male subfertility group following COS–IUI cycles for live birth rates was similar to those of the
endometriosis and unexplained subfertility groups.
Key words: Intrauterine insemination, assisted reproductive technology, fertility etiology

1. Introduction
Subfertility is defined as the failure to conceive after 1 year
of regular, unprotected intercourse. It affects approximately
8%–15% of couples [1]. Intrauterine insemination (IUI) is
a procedure in which processed and concentrated motile
sperm are placed directly into the uterine cavity with an
insemination canula. Intrauterine insemination, with or
without ovarian stimulation, is frequently used as a first line
infertility treatment because it is a relatively inexpensive,
less invasive, and effective method which is indicated
for different subfertility etiologies [2–4]. Mild male
subfertility, minimal–mild endometriosis, unexplained
subfertility, and several physical–psychosexual problems
are major indications for IUI [5]1.
The intrauterine insemination procedure can be
applied with normal menstrual cycles or controlled
ovarian stimulation (COS). Clomiphene citrate, letrozole,
or gonadotropins can be used for COS. Furthermore,
it is reported that the best pregnancy rate is achieved by

COS–IUI using gonadotropins when compared to other
treatments [6–8].
The live birth rate with the IUI procedure has been
reported as between 8.5% and 12.2% in different studies
[9]. There is sufficient evidence that COS–IUI improves
pregnancy rates in unexplained subfertility and miminal–
mild endometriosis, but its value for mild male factor
subfertility is still debated [4,10–14]. The aim of the
present study was to compare live birth rates after COS–
IUI in subfertile patients with male infertility, minimal–
mild endometriosis, and unexplained infertility.
2. Materials and methods
Data of all infertile couples who underwent COS–IUI in
a university-based fertility center between 2015 and 2016
were collected retrospectively from medical records. The
first cycles of each couple in our unit were analyzed to
prevent crossover bias. The present study was approved by
the Institutional Review Board (approval no: 050.01.04-

National Institute for Health and Clinical Excellence (NICE) guidelines. 2013 Feb. https://www.nice.org.uk/guidance/cg156/ifp/
chapter/intrauterine-insemination.
1
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E.8946). The inclusion criteria were age between 18 and
35 years and a treatment plan of IUI. The exclusion criteria
were stage 3 or 4 endometriosis, decreased ovarian reserve
(a serum FSH level greater than 12 IU/L or a baseline
follicle count 8 or less) [15,16], recurrent pregnancy loss
(two or more miscarriages), and advanced male factor
infertility (total motile sperm count less than 5 × 106) [17].
All couples underwent standard infertility evaluation prior
to IUI including hysterosalpingography, semen analysis,
baseline serum hormonal assays, midluteal progesterone
levels, and transvaginal ultrasonography. Semen analysis
was done according to World Health Organization criteria
(2010).
Three groups of patients were included in this study:
minimal–mild endometriosis, unexplained infertility,
and mild male factor infertility. All of the endometriosis
patients had already been diagnosed by laparoscopic
procedure indicated according to basal infertility
examination; minimal–mild endometriosis patients
according to American Fertility Society scoring were
included in this study. During laparoscopy, endometriotic
nodules were cauterized or excised and pelvic adhesions
were lysed to achieve normal pelvic anatomy. In addition,
chromopertubation was performed to assess tubal patency.
Controlled ovarian stimulation and an IUI procedure
were planned for the earliest following surgery. None of
the patients in the endometriosis group were administered
any adjuvant hormonal therapy before the COS–IUI cycle.
The mild male subfertility group was defined by semen
samples with a total motile sperm count (TMSC) <20 ×
106/mL, normal morphology <30%, or progressive motility
(grade A + B) <40% before sperm preparation.
Ovulation induction was achieved with gonadotropin
injection. Injections were administered daily, starting on
day 2 or 3 of the menstrual cycle. The dose was adjusted
according to ultrasonographic findings. Ovulation was
triggered by recombinant hCG when at least one follicle
was greater than 18 mm in mean diameter. Single IUI
was performed with a disposable catheter 36 hours after
ovulation was triggered. Semen was collected in sterile
containers by masturbation after 2–4 days’ refrain from
ejaculation. The continuous density gradient centrifugation
technique was performed for semen processing by a single
technician. The luteal phase was supported by vaginal
progesterone preparations daily (200 mg 1 × 1 daily).
Two weeks after insemination, plasma β-hCG levels were
measured. The primary outcome measure was live birth
rate.
Data analyses were performed by using SPSS Version
21.0 (IBM Corporation, Armonk, NYC, USA). A Shapiro–
Wilk test was used to test distribution of normality.
According to the results, parametric tests were preferred.
Continuous variables were compared with a one-way
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ANOVA test. Categorical variables were compared with
a chi-square test. A P value of <0.05 was considered
statistically significant.
3. Results
In total, 218 couples were included in this study. There
were 42 (19.2%) couples in the endometriosis group, 116
(53.2%) couples in the unexplained infertility group, and
60 (27.6%) couples in the mild male infertility group. Basic
demographic characteristics are presented in Table 1. The
groups had similar demographic characteristics. The mean
time interval between laparoscopic surgery and IUI was 2.1
± 1.7 months in the endometriosis group. The mean TMSC
of the mild male infertility group was 12.1 × 106, which was
significantly lower than for the other groups (P < 0.001).
The live birth rate of the entire study population was
9.6%. The live birth rates were 11.9%, 10.3%, and 6.6%,
respectively, in the endometriosis, unexplained infertility,
and mild male infertility groups (P = 0.63). In addition,
there were no statistically significant differences between
the groups for biochemical pregnancy and miscarriage
rates (Table 2).
4. Discussion
In this study, we compared live birth rates between
subfertile couples with mild male infertility, minimal–mild
endometriosis, and unexplained infertility, and observed
that live birth rates were similar between the groups.
Controlled ovarian stimulation and IUI increases
pregnancy rates in subfertile women regardless of infertility
etiology; IUI without ovarian stimulation has no effect on
live birth rates [18–22]. However, previous studies did not
compare the pregnancy rates between different subfertility
groups. A recent study from Brazil which included 237 IUI
cycles in 198 patients concluded that infertility etiology
did not affect pregnancy rates [23]. Although their results
seem similar to ours, the primary outcome of that study
was clinical pregnancy rate, not live birth rate. This was the
greatest limitation of that study.
Intrauterine insemination is a frequently used treatment
option for subfertile couples. In our study, live birth rates
were 10.3% and 11.9% in the unexplained infertility
and endometriosis groups, respectively. Werbrouck et
al. reported that pregnancy rates were similar between
unexplained infertility and minimal–mild endometriosis
groups (AFS stage I/II) within 6 months after surgical
treatment [24]. Prado-Perez et al. also found no statistically
significant differences in pregnancy rates of couples with
unexplained infertility and stage I or II endometriosis who
underwent IUI treatment [25]. The results of our study were
in accordance with those of the aforementioned studies
which showed similar live birth rates between unexplained
infertility and minimal–mild endometriosis.
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Table 1. Demographic characteristics of subfertility groups.
Endometriosis
(n = 42)

Unexplained
(n = 116)

Mild Male
(n = 60)

P-value

Age, years

2 ± 9.1 ± 5.1

28.4 ± 4.3

29.2 ± 4.8

0.48

Duration of infertility, years

3.8 ± 1.9

3.6 ± 2.1

4.1 ± 2.5

0.35

Previous IUI, n (%)

2 (4.7)

7 (5.1)

4 (6.6)

0.92

Unilateral tubal blockage, n (%)

4 (9.5)

10 (8.6)

7 (11.6)

0.81

Mean antral follicle count

9.2 ± 1.1

9.1 ± 0.9

8.9 ± 0.7

0.20

Baseline FSH, IU/mL

7.9 ± 2.3

7.4 ± 3.1

7.7 ± 2.8

0.58

E2 (pg/mL)

40.2 ± 19.2

48.3 ± 18.3

46.8 ± 20.2

0.06

PRL (ng/mL)

18 ± 7.1

15.2 ± 7.2

17.2 ± 8.9

0.07

TSH (mIU/L)

2.1 ± 0.8

2.2 ± 0.9

1.9 ± 0.9

0.29

Total gonadotropin dose (IU)

970.4 ± 180.2

980.3 ± 170.3

930.4 ± 200.4

0.21

Duration of stimulation (days)

12.8 ± 3.9

11.0 ± 4.4

11.8 ± 4.3

0.60

TMSC (×106)

47.9 ± 7.2

44.3 ± 8.2

12.1 ± 4.1

<0.001

Note: The values are presented as mean. AFC: Atrial follicular count; TMSC: total motile sperm count.

Table 2. The pregnancy outcome among subfertility groups.
Endometriosis group
(n = 42)

Unexplained group
(n = 116)

Mild male group
(n = 60)

P

Biochemical pregnancy (%)

7 (16.6)

15 (12.9)

9 (15)

0.82

Live birth (%)

5 (11.9)

12 (10.3)

4 (6.6)

0.63

Miscarriage, 2(%)

2 (4.7)

3 (2.6)

5 (8.4)

0.22

Although there was no statistically significant
difference in live birth rate between different subfertility
groups, it is important to note that the highest live birth
rate was found in the endometriosis group (11.9%). Several
studies have suggested lower pregnancy rates in couples
with endometriosis than others following IUI [26,27].
However, we failed to demonstrate such a result. This
might be as a result of the low number of subjects, as well
as surgical treatment of endometriosis by laparoscopy. The
benefits of laparoscopic surgery on pregnancy rates were
also demonstrated in a previous Cochrane review [28].
In our study, complete laparoscopic surgical removal was
performed in the endometriosis group before COS–IUI
treatment, which could have increased the live birth rate.
Miller et al. reported a 12.4% pregnancy rate per
cycle when the TMSC was over 20 million, and 7.4%
when the TMSC was between 10 and 20 million [29]. In
our study, we found that the biochemical pregnancy rate
was 15% and the live birth rate was 6.6% when mean
TMSC was 11.6 million, which was in accordance with

the abovementioned study. In the mild male infertility
group, the miscarriage rate was the highest of all of the
groups. We could not analyze any data other than motility
with a spermiogram. The high miscarriage rate in the
mild male infertility group could be related to sperm
morphology, but we cannot comment further about the
effect of the spermiogram because of the limitations of
the retrospective study. On the other hand, a recent study
which included 501 couples stated that abnormal sperm
morphology did not impact live birth rates [30].
Success of IUI treatment is still a debate of importance
for subfertile couples. The most recent NICE 2013
guidelines advised against offering routine IUI for people
with unexplained infertility, mild endometriosis, or mild
male factor infertility who are having regular unprotected
sexual intercourse. According to the NICE guidelines,
IVF should be considered after 2 years of unsuccessful
conception2. On the contrary, a recent review from 2017
suggested that IUI procedure should be undergone at least
3 cycles prior to in vitro fertilization (IVF) in couples with

National Institute for Health and Clinical Excellence (NICE) guidelines. 2013 Feb.https://www.nice.org.uk/guidance/cg156/ifp/
chapter/intrauterine-insemination.
2
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unexplained infertility and for men with a TMSC of >10
million [31]. No suggestion was presented for patients
with mild endometriosis in that paper. According to the
recent Cochrane review concerning male subfertility,
there is no evidence of a difference in live birth rates
between COS–IUI and timed intercourse [14]. They
reported that this result was very low-quality evidence. On
the other hand, we found similar pregnancy rates between
the study groups. Although we did not compare live birth
rates between subfertility etiology and timed intercourse,
our results, especially in the male subfertility group, are
valuable. We suggest COS–IUI treatment should be
considered in couples with male subfertility before IVF
procedures because of its substantial live birth rate, its
simplicity, and low cost.
The main strengths of the present study were using live
birth rate as the primary outcome measure and evaluating

only the first COS–IUI cycle of each couple to prevent
crossover bias. The major limitations of our study were
the retrospective design and the low number of subjects,
particularly in the endometriosis group. However, we
could not include more subjects in such a study using
strict inclusion and exclusion criteria conducted in a single
center. Another limitation of the study was the lack of a
hypothetical power analysis.
In conclusion, different subfertility etiologies do
not affect the success of COS–IUI treatment in terms of
live birth rate. The success rate of mild male subfertility
following a COS–IUI cycle for live birth rates is similar
to those of the endometriosis and unexplained subfertility
groups. Further large prospective studies are needed to
determine the exact effect of subfertility etiology on the
success of COS–IUI treatment.
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